These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 20652780)
1. Application of quantitative pharmacology in development of therapeutic monoclonal antibodies. Tabrizi M; Funelas C; Suria H AAPS J; 2010 Dec; 12(4):592-601. PubMed ID: 20652780 [TBL] [Abstract][Full Text] [Related]
2. Translational strategies for development of monoclonal antibodies from discovery to the clinic. Tabrizi MA; Bornstein GG; Klakamp SL; Drake A; Knight R; Roskos L Drug Discov Today; 2009 Mar; 14(5-6):298-305. PubMed ID: 19152840 [TBL] [Abstract][Full Text] [Related]
3. Translational pharmacokinetics and pharmacodynamics of monoclonal antibodies. Kamath AV Drug Discov Today Technol; 2016; 21-22():75-83. PubMed ID: 27978991 [TBL] [Abstract][Full Text] [Related]
4. Modeling, simulation, and translation framework for the preclinical development of monoclonal antibodies. Luu KT; Kraynov E; Kuang B; Vicini P; Zhong WZ AAPS J; 2013 Apr; 15(2):551-8. PubMed ID: 23408094 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients. Temrikar ZH; Suryawanshi S; Meibohm B Paediatr Drugs; 2020 Apr; 22(2):199-216. PubMed ID: 32052309 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies: what are the pharmacokinetic and pharmacodynamic considerations for drug development? Deng R; Jin F; Prabhu S; Iyer S Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):141-60. PubMed ID: 22248267 [TBL] [Abstract][Full Text] [Related]
11. Impact of Shed/Soluble targets on the PK/PD of approved therapeutic monoclonal antibodies. Samineni D; Girish S; Li C Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1557-1569. PubMed ID: 27766899 [TBL] [Abstract][Full Text] [Related]
14. "Fit-for-purpose" method validation and application of a biomarker (C-terminal telopeptides of type 1 collagen) in denosumab clinical studies. Wang J; Lee J; Burns D; Doherty D; Brunner L; Peterson M; DeSilva B AAPS J; 2009 Jun; 11(2):385-94. PubMed ID: 19462251 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of monoclonal antibodies: concepts and lessons for drug development. Mould DR; Green B BioDrugs; 2010 Feb; 24(1):23-39. PubMed ID: 20055530 [TBL] [Abstract][Full Text] [Related]
16. Application and potential limitations of animal models utilized in the development of trastuzumab (Herceptin): a case study. Pegram M; Ngo D Adv Drug Deliv Rev; 2006 Aug; 58(5-6):723-34. PubMed ID: 16876287 [TBL] [Abstract][Full Text] [Related]